Drug Type Small molecule drug |
Synonyms BAY 8400, BAY8400 |
Target |
Action inhibitors |
Mechanism PRKDC inhibitors(DNA-dependent protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Molecular FormulaC21H17F2N5O |
InChIKeyATKHYZXUMVNCIO-UHFFFAOYSA-N |
CAS Registry2763602-59-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Prostatic Cancer | Preclinical | Germany | 24 Aug 2021 |





